Funding Opportunity RFA-AA-20-011 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits cooperative agreements to participate in two consortia under the Integrative Neuroscience Initiative on Alcoholism (INIA). This FOA solicits submission of administrative resource cores (U24) applications. Please see companion FOAs for submission of resource-related and support cores (U24) applications, RFA-AA-20-012, and for submission of collaborative research projects (U01) applications, RFA-AA-20-013 .

Funding Opportunity PAR-21-028 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) intends to support investigators who have interest and capability to join efforts for the discovery of cell-based chemical probes for novel brain targets. It is expected that applicants will have in hand the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds. Through this FOA, NIH wishes to stimulate research in: 1) discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of NIMH, NIA, NICHD, and/or NIDCD; and 2) discovery and/or validation of novel, biological targets that will inform studies of brain disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease-related biological targets and biological processes. The main emphasis of projects submitted under this FOA should be in the discovery of cell-based chemical probes. Applicants interested in developingin vivochemical probes may wish to apply using the companion R01 mechanism TEMP-8444.

Funding Opportunity PAR-21-029 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) intends to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have in hand the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds. Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of NIMH, NEI, NIAAA, NIDA, NIA and/or NIDCD and 2) discovery and/or validation of novel, biological targets that will inform studies of brain disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease-related biological targets and biological processes. The main emphasis of projects submitted under this FOA should be in the discovery of in vivo chemical probes. Applicants interested in developing cell-based chemical probes may wish to apply using the companion R21 mechanism TEMP-8443.

We are on an exciting mission to make a real difference in science and healthcare. There are few players who have shaped the world of modern science and…
From QIAGEN - Wed, 14 Oct 2020 12:45:50 GMT - View all Midwest, WY jobs

Competitive Salary: EMBL: Scientific Training Officer (Supernumerary) Location Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: Scientific Training Officer (Staff Member) Location: Cambridge, Cambridgeshire, England

Funding Opportunity PAR-21-046 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications for the preparation of book-length manuscripts and other works of academic and/or public health policy value to U.S. health professionals, public health officials, biomedical researchers and historians of the health sciences.

Funding Opportunity RFA-CA-20-050 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) and National Institute of Environmental Health Sciences (NIEHS) will support a Coordinating Center to facilitate coordination across the new Cohorts for Environmental Exposures and Cancer Risk (CEECR) (see UG3/UH3 phased awards supported under companion RFA-CA-20-049). The overarching goal of the CEECR is to support innovative scientific research in new prospective cohorts to address knowledge gaps between environmental exposures and cancer etiology, and the genetic, lifestyle, and behavioral factors that modify risk across diverse populations. The Coordinating Center will have several responsibilities, including, but not limited to provide administrative support to the CEECR program, create standard operating procedures and best practices to collect core common data elements and biological samples, facilitate communication across cohorts, provide meeting support, create and maintain the CEECR websites, and facilitate deposition of data to NIH repositories.

Funding Opportunity RFA-CA-20-049 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications to support innovative scientific research in new prospective cohorts that addresses knowledge gaps in cancer etiology and carcinogenesis process with a focus on environmental exposures. Applicants are encouraged to use validated and reproducible innovative techniques to measure environmental exposures relevant to the proposed scientific research questions. The cohorts should include racial/ethnic minorities and understudied populations to address the unequal burden of cancer that currently exists in those populations. In this FOA, environmental exposures refer to physical, chemical, and biological factors external to a person, and related behavioral factors. This FOA is published in parallel with RFA-CA-20-050 New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed). Prospective cohorts and the Coordinating Center funded under these FOAs together will constitute the Cohorts for Environmental Exposure and Cancer Risk (CEECR) program.

Notice NOT-MH-21-016 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-024 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-012 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-023 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-027 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-026 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-025 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-022 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-021 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-020 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-035 from the NIH Guide for Grants and Contracts